Nanhua Biotech (000504.SZ): Net loss of 2.777 million yuan in the first quarter

Gelonghui, April 29丨Nanhua Biotech (000504.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 25.973,900 yuan, down 25.23% from the previous year; net profit attributable to shareholders of listed companies was 2.777 million yuan; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss - 3.834 million yuan; basic earnings per share.

Gelonghui FinanceApr 29 22:58

Express News | Nanhua Biotech: All 10.79% of the company's shares held by Shanghai Heping, the second-largest shareholder will be judicially auctioned

BreakingsFeb 27 20:56

Nanhua Biotech (000504.SZ): Pre-loss of 19 million yuan to 28 million yuan in 2023

Gelonghui, January 26 | Nanhua Biotech (000504.SZ) announced its 2023 annual results forecast. Net profit loss attributable to shareholders of listed companies during the reporting period was 19 million yuan to 28 million yuan, down 49.67 percent- 120.56% from the same period last year; net profit loss after deducting non-recurring profit and loss was 33.5 million yuan — 42.5 million yuan, down 45.33% -84.38% from the same period last year; basic earnings loss per share was 0.058 yuan/share — 0.085 yuan/share. Reasons for changes in performance: 1. During the reporting period, company cells

Gelonghui FinanceJan 26 16:44

The court froze 10.79% of the shares held by Shanghai Heping, the majority shareholder of Nanhua Biotech (000504.SZ)

Nanhua Biotech (000504.SZ) issued an announcement. The company recently received an issuance from China Securities Registration and Settlement Co., Ltd...

Zhitong FinanceJan 22 19:48

Nanhua Biotech (000504.SZ): Net profit for the third quarter was 9.4599 million yuan, up 681.72% year on year

On October 30, Gelonghui Biotech (000504.SZ) announced its report for the third quarter of 2023. Operating income for the reporting period was 34.3262 million yuan, down 26.38% year on year; net profit attributable to shareholders of listed companies was 9.4599 million yuan, up 681.72% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss - 463443 million yuan; basic earnings per share of 0.0304 yuan.

Gelonghui FinanceOct 30, 2023 19:12

Nanhua Biotech (000504.SZ): At present, it has developed the EE18 series of products, mainly essences, masks, creams, etc.

GLONGHUI September 18丨An investor asked Nanhua Biotech (000504.SZ) on the investor interactive platform, “How are the company's medical and aesthetic products progressing?” The company replied that the company has now developed the EE18 series of products, mainly essences, masks, creams, etc. In addition, the company also has some products under development.

Gelonghui FinanceSep 18, 2023 16:18